BCMA as a Target in Heavily Pre-Treated RRMM

home / insights / bcma-as-a-target-in-heavily-pre-treated-rrmm

Treatment Approach for R/R Multiple Myeloma

EP. 1: Treatment Approach for R/R Multiple Myeloma

Sagar Lonial, MD, FACP, Winship Cancer Institute of Emory University;Asim V. Farooq, MD, University of Chicago Medical Center;Natalie S. Callander, MD, University of Washington Carbone Cancer Center
December 18th 2020
The Rationale for Targeting BCMA in Multiple Myeloma

EP. 2: The Rationale for Targeting BCMA in Multiple Myeloma

Sagar Lonial, MD, FACP, Winship Cancer Institute of Emory University;Asim V. Farooq, MD, University of Chicago Medical Center;Natalie S. Callander, MD, University of Washington Carbone Cancer Center
December 18th 2020
DREAMM-2 Trial Efficacy Data and Recent FDA Approval

EP. 3: DREAMM-2 Trial Efficacy Data and Recent FDA Approval

Sagar Lonial, MD, FACP, Winship Cancer Institute of Emory University;Asim V. Farooq, MD, University of Chicago Medical Center;Natalie S. Callander, MD, University of Washington Carbone Cancer Center
January 18th 2021
DREAMM-2 Trial Regimen Safety Profile

EP. 4: DREAMM-2 Trial Regimen Safety Profile

Sagar Lonial, MD, FACP, Winship Cancer Institute of Emory University;Asim V. Farooq, MD, University of Chicago Medical Center;Natalie S. Callander, MD, University of Washington Carbone Cancer Center
January 18th 2021
Management of Ocular Events From DREAMM-2 Regimen

EP. 5: Management of Ocular Events From DREAMM-2 Regimen

Sagar Lonial, MD, FACP, Winship Cancer Institute of Emory University;Asim V. Farooq, MD, University of Chicago Medical Center;Natalie S. Callander, MD, University of Washington Carbone Cancer Center
January 25th 2021
DREAMM-2 Trial Regimen: Safety Updates and Dose Delay

EP. 6: DREAMM-2 Trial Regimen: Safety Updates and Dose Delay

Sagar Lonial, MD, FACP, Winship Cancer Institute of Emory University;Asim V. Farooq, MD, University of Chicago Medical Center;Natalie S. Callander, MD, University of Washington Carbone Cancer Center
January 25th 2021
Next Steps for Use of Belantamab in Clinical Practice

EP. 7: Next Steps for Use of Belantamab in Clinical Practice

Sagar Lonial, MD, FACP, Winship Cancer Institute of Emory University;Asim V. Farooq, MD, University of Chicago Medical Center;Natalie S. Callander, MD, University of Washington Carbone Cancer Center
February 1st 2021
Ongoing Approaches Toward Targeting BCMA

EP. 8: Ongoing Approaches Toward Targeting BCMA

Sagar Lonial, MD, FACP, Winship Cancer Institute of Emory University;Asim V. Farooq, MD, University of Chicago Medical Center;Natalie S. Callander, MD, University of Washington Carbone Cancer Center
February 1st 2021
Influencing Factors to Initially Targeting BCMA in MM

EP. 9: Influencing Factors to Initially Targeting BCMA in MM

Sagar Lonial, MD, FACP, Winship Cancer Institute of Emory University;Asim V. Farooq, MD, University of Chicago Medical Center;Natalie S. Callander, MD, University of Washington Carbone Cancer Center
February 1st 2021